Advertisement

Topics

Progenics Pharmaceuticals Inc. (PGNX) Given New $11.00 Price Target at BTIG Research

23:36 EST 30 Nov 2016 | Topix

BTIG Research's target price would suggest a potential upside of 22.91% from the stock's previous close. PGNX has been the subject of a number of other research reports.

Original Article: Progenics Pharmaceuticals Inc. (PGNX) Given New $11.00 Price Target at BTIG Research

NEXT ARTICLE

More From BioPortfolio on "Progenics Pharmaceuticals Inc. (PGNX) Given New $11.00 Price Target at BTIG Research"

Quick Search
Advertisement